{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:24:36Z","timestamp":1761128676097},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,5,10]],"date-time":"2008-05-10T00:00:00Z","timestamp":1210377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00105-008-1533-z","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T09:45:34Z","timestamp":1210239934000},"page":"724-727","source":"Crossref","is-referenced-by-count":5,"title":["Ein Fall von granulomat\u00f6ser Rosazea im zeitlichen Zusammenhang mit Etanercept","A case of granulomatous rosacea coinciding with the use of etanercept"],"prefix":"10.1007","volume":"59","author":[{"given":"U.M.","family":"Winter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Treudler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Paasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sticherling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,10]]},"reference":[{"key":"1533_CR1","doi-asserted-by":"crossref","unstructured":"Cabou C, Bagheri H, Cantagrel A et al. (2003) Retrospective analysis of adverse effects of infliximab in a hospital rheumatology service. Therapie. 58(5): 457\u2013462","DOI":"10.2515\/therapie:2003074"},{"key":"1533_CR2","first-page":"198","volume":"142","author":"Deng","year":"2006","unstructured":"Deng A, Harvey V, Sina B et al. (2006) Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol 142(2): 198\u2013202","journal-title":"Arch Dermatol"},{"key":"1533_CR3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","volume":"156","author":"Lee","year":"2007","unstructured":"Lee HH et al. (2007) Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 156(3): 486","journal-title":"Br J Dermatol"},{"key":"1533_CR4","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1086\/429996","volume":"1","author":"Wallis","year":"2005","unstructured":"Wallis RS, Broder M, Wong J et al. (2005) Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis 1(41 Suppl 3): S194\u2013198","journal-title":"Clin Infect Dis"},{"key":"1533_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","volume":"36","author":"Furst","year":"2006","unstructured":"Furst DE, Wallis R, Broder M, Beenhouwer DO (2006) Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in risk for developing granulomatous infections. Semin Arthritis Rheum 36(3): 159\u2013157","journal-title":"Semin Arthritis Rheum"},{"key":"1533_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semarthrit.2005.01.009","volume":"34","author":"Wallis","year":"2005","unstructured":"Wallis RS, Ehlers S (2005) Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum 34(5 Suppl1): 34\u201339","journal-title":"Semin Arthritis Rheum"},{"key":"1533_CR7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jbspin.2006.05.017","volume":"74","author":"Mathieu","year":"2007","unstructured":"Mathieu S et al. (2007) Cat scratch disease during etanercept therapy. Joint Bone Spin 74(2): 184\u2013186","journal-title":"Joint Bone Spin"},{"key":"1533_CR8","first-page":"1888","volume":"31","author":"Beenhouwer","year":"2004","unstructured":"Beenhouwer D, Wallis R, Broder M, Furst DE (2004) Mechanisms of action of tumor necrosis factor antagonist and granulomatous infections. J Rheumatol 31(10): 1888\u20131892","journal-title":"J Rheumatol"},{"key":"1533_CR9","doi-asserted-by":"crossref","unstructured":"Wallis RS et al. (2004) Granulomaous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 1;38(9): 1261\u20131265","DOI":"10.1086\/383317"},{"key":"1533_CR10","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s10067-007-0594-1","volume":"26","author":"Verschueren","year":"2007","unstructured":"Verschueren K et al. (2007) Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol 26(11): 1969\u20131971","journal-title":"Clin Rheumatol"},{"key":"1533_CR11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2006.01949.x","volume":"21","author":"Bachmeyer","year":"2007","unstructured":"Bachmeyer C et. al. (2007) Granulomatous tattoo reaction in a patient treated with etanercept. J Eur Acad Dermatol Venerol 21(4): 550\u2013552","journal-title":"J Eur Acad Dermatol Venerol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1533-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-008-1533-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1533-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:30:26Z","timestamp":1708907426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-008-1533-z"}},"subtitle":["Kein Rezidiv unter Infliximab","No relapse with infliximab"],"short-title":[],"issued":{"date-parts":[[2008,5,10]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1007\/s00105-008-1533-z","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,10]]}}}